Cargando…
Clinical Benefit of Statins in Korean Patients with Acute Myocardial Infarction: Experience of the Korea Acute Myocardial Infarction Registry
Statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor) are among the most important medications for treating patients with acute myocardial infarction (AMI). Herein, we review the clinical benefit and future scope of statin therapy in Korean patients with AMI from the experience of the...
Autores principales: | Cho, Kyung Hoon, Jeong, Myung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Lipidology and Atherosclerosis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7521970/ https://www.ncbi.nlm.nih.gov/pubmed/33024731 http://dx.doi.org/10.12997/jla.2020.9.3.362 |
Ejemplares similares
-
New Horizons of Acute Myocardial Infarction: From the Korea Acute Myocardial Infarction Registry
por: Lee, Ki Hong, et al.
Publicado: (2013) -
Benefit of Early Statin Therapy in Acute Myocardial Infarction in Korea
por: Jeong, Han Saem, et al.
Publicado: (2019) -
Predictors of Recovery of Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: From the Korean Acute Myocardial Infarction Registry and Korean Myocardial Infarction Registry
por: Oh, Pyung Chun, et al.
Publicado: (2013) -
Differences in the Korea Acute Myocardial Infarction Registry Compared with Western Registries
por: Sim, Doo Sun, et al.
Publicado: (2017) -
The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry
por: Kim, Hyun Kuk, et al.
Publicado: (2014)